Woodford Investment Management’s Autolus Therapeutics AUTL Stock Holding History

Woodford Investment Management’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,095,127	Closed	-$26M	–	1
2019 Q3	$26M	Sell	2,095,127 -9,499,107	-82%	-$126M	8.39%	3
2019 Q2	$187M	Sell	11,594,234 -447,185	-4%	-$10M	31.58%	2
2019 Q1	$379M	Buy	12,041,419 +116,000	+1%	+$3.3M	30.59%	1
2018 Q4	$392M	Buy	11,925,419 +1,099,500	+10%	+$36.2M	33.87%	1
2018 Q3	$332M	Buy	10,825,919 +9,234,176	+580%	+$249M	26.44%	2
2018 Q2	$42.6M	Buy	+1,591,743	New	+$42.1M	5.17%	5

Other funds holding AUTL

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Woodford Investment Management's AUTL Position: Q4 2019 in Review

Woodford Investment Management sold out of Autolus Therapeutics (AUTL) in Q4 2019, closing a stake of 2,095,127 shares — an estimated $26M sold.

Woodford Investment Management first reported a position in AUTL in Q2 2018 and held it in 6 quarters. The position peaked at $392M in Q4 2018. 55 funds tracked by Wall St. Rank hold AUTL as of Q4 2019.

Woodford Investment Management reported no remaining Autolus Therapeutics position as of Q4 2019 after selling out during the quarter.
Woodford Investment Management sold 2,095,127 Autolus Therapeutics shares in Q4 2019, an estimated $26M.
Woodford Investment Management first reported a position in Autolus Therapeutics in Q2 2018 and held it in 6 quarters.
Woodford Investment Management's Autolus Therapeutics position peaked at $392M in Q4 2018.
55 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2019.

Based on Woodford Investment Management's 13F filing for Q4 2019.